FindTrial
Sign In

Improving antithrombotic treatment in atrial fibrillation

Clinical Decision Support System for improving adherence to ESC guidelines for antithrombotic treatment in atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25098
Enrollment
Unknown
Registered
2014-12-05
Start date
2015-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Prevention, Stroke

Interventions

A clinical decision support system integrated in the electronic health record (EHR) of the patient, that calculates the CHA2DS2-VASc score and HAS-BLED score based on the patient information stored in

Sponsors

Academic Medical Center (AMC), Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients: All patients with atrial fibrillation visisting one of the three selected hospitals in the Netherlands. Physicians: All cardiologists working in one of the three selected hospitals in the Netherlands (Franciscus Ziekenhuis Roosendaal, Lievensberg Ziekenhuis Bergen op Zoom, and Beatrixziekenhuis Gornichem).

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
The proportion of patients with non-valvular atrial fibrillation whose anti-thrombotic treatment prescription is in accordance with the ESC guideline for atrial fibrillation.—

Contacts

Public ContactR.J. van Brummelen
r.j.vanbrummelen@amc.uva.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)